Table 1

Clinical and biological data at presentation of patients with acute chest syndrome and a new pulmonary opacity on CT

At least one complete lung segment consolidation on CT
ParameterNo (n=55)Yes (n=84)p Value
Presence of a precipitating factor24 (44%)57 (68%)<0.01
Type of precipitating factor0.02
 Extrathoracic pain before ACS7 (13%)30 (15%)
 Surgery2 (4%)5 (6%)
 Infection2 (4%)6 (7%)
 Other13 (24%)16 (19%)
Symptoms
 Fever18 (34%)37 (45%)0.22
 Chest pain51 (96%)81 (96%)>0.99
 Extrathoracic pain during ACS47 (89%)60 (71%)0.02
 Haemoptysis0 (0%)2 (2%)0.52
 Cough22 (42%)34 (41%)0.91
 Pulmonary crackles39 (74%)71 (85%)0.12
 Jugular venous distension2 (4%)7 (8%)0.48
Blood pressure, mmHg
 Systolic120 [110–130]120 [114–130]0.07
 Diastolic66 [65–74]70 [65–76]0.20
Heart rate, beats/minute100 [99–120]110 [100–120]0.12
Respiratory rate, breaths/minute26 [24–28]28 [26–30]<0.01
Blood gases
 PaO2, mmHg74 [64–93]77 [65–96]0.49
 PaO2/FiO2 ratio, mmHg305±75285±1010.22
 PaCO2, mmHg43±744±60.21
 pH7.41±0.057.40±0.050.29
 HCO3, mmol/L28±328±30.98
 SaO2, %95 [90–97]94 [91–98]0.70
Laboratory values at ACS diagnosis
 White cell count, 109/L14.6±5.318.0±6.0<0.01
 Platelet count, 109/L353±143374±2180.54
Total haemoglobin, g/dL
  All patients9.1±1.58.7±1.60.26
  SS patients only (n=123 episodes)9.0±1.58.5±1.50.07
 Creatinine, µmol/L65±2160±280.24
 C-reactive protein, mg/L98±94141±940.02
 Alkaline phosphatase, IU/L 91 [73–126]101 [76–136]0.41
 Aspartate aminotransferase, IU/L48 [31–66]40 [29–68]0.40
 Alanine aminotransferase, IU/L28 [20–59]29 [18–48]0.89
 Total bilirubin, µmol/L45 [29–71]39 [26–64]0.57
 Direct bilirubin, µmol/L11 [7–15]12 [8–19]0.27
 Lactate dehydrogenase, IU/L552 [389–734]491 [360–652]0.17
CT
 Pulmonary artery thrombosis9 (16%)17 (20%)0.57
 Right ventricle/left ventricle ratio0.92 [0.81–1.05]0.91 [0.81–1.09]0.89
 Moderate to large pleural effusion6 (11%)27 (32%)<0.01
  • Data are presented as mean±SD, median [25th–75th percentiles] or number (percentage).

  • ACS, acute chest syndrome.